Tablets that stop the body from making testosterone or prevent testosterone from reaching the prostate cancer cells. For example, enzalutamide (Xtandi), apalutamide (Erleada), darolutamide (Nubeqa), abiraterone acetate (Zytiga) and bicalutamide (Casodex).